TOP2A and posterior cortical atrophy: It was found that ADT alone was insufficient to inhibit PCa cell survival in cases of TOP2A overexpression, which was also supported by our results that RSS-high group patients with higher TOP2A levels were less likely to benefit from ADT [52].